Chronic Kidney Disease (CKD) Market by Product Type and Application - Global Industry Analysis & Forecast to 2027
Published On : September 2019 Pages : 154 Category: Pharma & Healthcare Report Code : HC095775
Chronic Kidney Disease (CKD) Market by Product Type (Calcium channel blockers, Anemia Treatment Drugs, Antihypertensive, Others) Application (Hospital, Clinic) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The chronic kidney disease (CKD) market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Chronic kidney disease (CKD) normally deteriorates gradually, and side effects may not show up until kidneys are seriously harmed. The main risk factors for developing kidney disease are high blood pressure, diabetes, family history of kidney failure, heart disease.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Chronic Kidney Disease (CKD) Market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- AbbVie
- Kissei
- FibroGen
- Allergan
- Keryx
- Amgen
- Johnson & Johnson
- AstraZeneca
- GlaxoSmithKline
- Roche
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Chronic Kidney Disease (CKD) Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)
o Calcium channel blockers
o Anemia Treatment Drugs
o Antihypertensive
o Others
· Chronic Kidney Disease (CKD) Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Hospital
o Clinic
· Chronic Kidney Disease (CKD) Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o AbbVie
o Kissei
o FibroGen
o Allergan
o Keryx
o Amgen
o Johnson & Johnson
o AstraZeneca
o GlaxoSmithKline
o Roche
· Chronic Kidney Disease (CKD) Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Chronic Kidney Disease (CKD) Market, By Country
o U.S. Chronic Kidney Disease (CKD) Market
o Canada Chronic Kidney Disease (CKD) Market
o Mexico Chronic Kidney Disease (CKD) Market
o Europe
§ Europe Chronic Kidney Disease (CKD) Market, By Country
o Germany Chronic Kidney Disease (CKD) Market
o UK Chronic Kidney Disease (CKD) Market
o France Chronic Kidney Disease (CKD) Market
o Russia Chronic Kidney Disease (CKD) Market
o Italy Chronic Kidney Disease (CKD) Market
o Rest of Europe Chronic Kidney Disease (CKD) Market
o Asia-Pacific
§ Asia-Pacific Chronic Kidney Disease (CKD) Market, By Country
o China Chronic Kidney Disease (CKD) Market
o Japan Chronic Kidney Disease (CKD) Market
o South Korea Chronic Kidney Disease (CKD) Market
o India Chronic Kidney Disease (CKD) Market
o Southeast Asia Chronic Kidney Disease (CKD) Market
o Rest of Asia-Pacific Chronic Kidney Disease (CKD) Market
o South America
§ South America Chronic Kidney Disease (CKD) Market
o Brazil Chronic Kidney Disease (CKD) Market
o Argentina Chronic Kidney Disease (CKD) Market
o Columbia Chronic Kidney Disease (CKD) Market
o Rest of South America Chronic Kidney Disease (CKD) Market
o Middle East and Africa
§ Middle East and Africa Chronic Kidney Disease (CKD) Market
o Saudi Arabia Chronic Kidney Disease (CKD) Market
o UAE Chronic Kidney Disease (CKD) Market
o Egypt Chronic Kidney Disease (CKD) Market
o Nigeria Chronic Kidney Disease (CKD) Market
o South Africa Chronic Kidney Disease (CKD) Market
o Rest of MEA Chronic Kidney Disease (CKD) Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Chronic Kidney Disease (CKD) Market, By Product Type
5.1. Introduction
5.2. Global Chronic Kidney Disease (CKD) Revenue and Market Share by Product Type (2017-2027)
5.2.1. Global Chronic Kidney Disease (CKD) Revenue and Revenue Share by Product Type (2017-2027)
5.3. Calcium channel blockers
5.3.1. Global Calcium channel blockers Revenue and Growth Rate (2017-2027)
5.4. Anemia Treatment Drugs
5.4.1. Global Anemia Treatment Drugs Revenue and Growth Rate (2017-2027)
5.5. Antihypertensive
5.5.1. Global Antihypertensive Revenue and Growth Rate (2017-2027)
5.6. Others
5.6.1. Global Others Revenue and Growth Rate (2017-2027)
6. Chronic Kidney Disease (CKD) Market, By Application
6.1. Introduction
6.2. Global Chronic Kidney Disease (CKD) Revenue and Market Share by Application (2017-2027)
6.2.1. Global Chronic Kidney Disease (CKD) Revenue and Revenue Share by Application (2017-2027)
6.3. Hospital
6.3.1. Global Hospital Revenue and Growth Rate (2017-2027)
6.4. Clinic
6.4.1. Global Clinic Revenue and Growth Rate (2017-2027)
7. Chronic Kidney Disease (CKD) Market, By Region
7.1. Introduction
7.2. Global Chronic Kidney Disease (CKD) Revenue and Market Share by Regions
7.2.1. Global Chronic Kidney Disease (CKD) Revenue by Regions (2017-2027)
7.3. North America Chronic Kidney Disease (CKD) by Countries
7.3.1. North America Chronic Kidney Disease (CKD) Revenue and Growth Rate (2017-2027)
7.3.2. North America Chronic Kidney Disease (CKD) Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Chronic Kidney Disease (CKD) by Countries
7.4.1. Europe Chronic Kidney Disease (CKD) Revenue and Growth Rate (2017-2027)
7.4.2. Europe Chronic Kidney Disease (CKD) Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Chronic Kidney Disease (CKD) by Countries
7.5.1. Asia-Pacific Chronic Kidney Disease (CKD) Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Chronic Kidney Disease (CKD) Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Chronic Kidney Disease (CKD) by Countries
7.6.1. South America Chronic Kidney Disease (CKD) Revenue and Growth Rate (2017-2027)
7.6.2. South America Chronic Kidney Disease (CKD) Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Chronic Kidney Disease (CKD) by Countries
7.7.1. Middle East and Africa Chronic Kidney Disease (CKD) Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Chronic Kidney Disease (CKD) Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. AbbVie
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Kissei
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. FibroGen
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Allergan
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Keryx
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Amgen
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Johnson & Johnson
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. AstraZeneca
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. GlaxoSmithKline
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Roche
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.1. Global Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Chronic Kidney Disease (CKD) Market Forecast by Regions (2017-2027)
9.2.1. North America Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.1.1. United States Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.1.2. Canada Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.1.3. Mexico Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.2. Europe Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.2.1. Germany Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.2.2. France Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.2.3. UK Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.2.4. Russia Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.2.5. Italy Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.3. Asia-Pacific Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.3.1. China Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.3.2. Japan Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.3.3. Korea Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.3.4. India Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.4. South America Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.4.1. Brazil Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.4.2. Argentina Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.4.3. Columbia Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.4.4. Rest of South America Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.5. Middle East and Africa Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.5.3. Egypt Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.5.4. Nigeria Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.5.5. South Africa Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.5.6. Turkey Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Chronic Kidney Disease (CKD) Market Forecast (2017-2027)
9.3. Chronic Kidney Disease (CKD) Market Forecast by Product Type (2017-2027)
9.3.1. Chronic Kidney Disease (CKD) Forecast by Product Type (2017-2027)
9.3.2. Chronic Kidney Disease (CKD) Market Share Forecast by Product Type (2017-2027)
9.4. Chronic Kidney Disease (CKD) Market Forecast by Application (2017-2027)
9.4.1. Chronic Kidney Disease (CKD) Forecast by Application (2017-2027)
9.4.2. Chronic Kidney Disease (CKD) Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Chronic Kidney Disease (CKD) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Chronic Kidney Disease (CKD) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Chronic Kidney Disease (CKD) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Chronic Kidney Disease (CKD) Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Chronic Kidney Disease (CKD) Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Chronic Kidney Disease (CKD) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Chronic Kidney Disease (CKD) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Chronic Kidney Disease (CKD) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Chronic Kidney Disease (CKD) Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Chronic Kidney Disease (CKD) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Chronic Kidney Disease (CKD) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Chronic Kidney Disease (CKD) Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Chronic Kidney Disease (CKD) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Chronic Kidney Disease (CKD) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Chronic Kidney Disease (CKD) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Chronic Kidney Disease (CKD) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Chronic Kidney Disease (CKD) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Chronic Kidney Disease (CKD) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Chronic Kidney Disease (CKD) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Chronic Kidney Disease (CKD) Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Chronic Kidney Disease (CKD) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Chronic Kidney Disease (CKD) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Chronic Kidney Disease (CKD) Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Chronic Kidney Disease (CKD) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Chronic Kidney Disease (CKD) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Chronic Kidney Disease (CKD) Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Chronic Kidney Disease (CKD) Revenue and Revenue Share by Product Type (2017-2018)
Figure Global Calcium channel blockers Revenue and Growth Rate (2017-2018)
Figure Global Anemia Treatment Drugs Revenue and Growth Rate (2017-2018)
Figure Global Antihypertensive Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Chronic Kidney Disease (CKD) Revenue and Revenue Share by Application (2017-2018)
Figure Global Hospital Revenue and Growth Rate (2017-2018)
Figure Global Clinic Revenue and Growth Rate (2017-2018)
Table Global Chronic Kidney Disease (CKD) Revenue by Regions (2017-2018)
Figure North America Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure North America Chronic Kidney Disease (CKD) Revenue and Growth Rate (2017-2018)
Figure North America Chronic Kidney Disease (CKD) by Countries (2017-2018)
Figure North America Chronic Kidney Disease (CKD) Revenue (Million USD) by Countries (2017-2018)
Figure United States Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure United States Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure Canada Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure Mexico Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure Europe Chronic Kidney Disease (CKD) Revenue and Growth Rate (2017-2018)
Figure Europe Chronic Kidney Disease (CKD) by Countries (2017-2018)
Figure Europe Chronic Kidney Disease (CKD) Revenue (Million USD) by Countries (2017-2018)
Figure Germany Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure Germany Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure France Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure UK Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure Russia Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure Italy Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure Rest of Europe Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure Asia-Pacific Chronic Kidney Disease (CKD) Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Chronic Kidney Disease (CKD) by Countries (2017-2018)
Figure Asia-Pacific Chronic Kidney Disease (CKD) Revenue (Million USD) by Countries (2017-2018)
Figure China Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure China Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure Japan Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure Korea Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure India Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure Southeast Asia Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure South America Chronic Kidney Disease (CKD) Revenue and Growth Rate (2017-2018)
Figure South America Chronic Kidney Disease (CKD) by Countries (2017-2018)
Figure South America Chronic Kidney Disease (CKD) Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure Brazil Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure Argentina Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure Columbia Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure Rest of South America Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure Middle East and Africa Chronic Kidney Disease (CKD) Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Chronic Kidney Disease (CKD) by Countries (2017-2018)
Figure Middle East and Africa Chronic Kidney Disease (CKD) Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure Saudi Arabia Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure United Arab Emirates Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure Egypt Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure Nigeria Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure South Africa Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure Turkey Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Chronic Kidney Disease (CKD) Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2017-2018)
Table AbbVie Chronic Kidney Disease (CKD) Financial Overview
Table Kissei Chronic Kidney Disease (CKD) Financial Overview
Table FibroGen Chronic Kidney Disease (CKD) Financial Overview
Table Allergan Chronic Kidney Disease (CKD) Financial Overview
Table Keryx Chronic Kidney Disease (CKD) Financial Overview
Table Amgen Chronic Kidney Disease (CKD) Financial Overview
Table Johnson & Johnson Chronic Kidney Disease (CKD) Financial Overview
Table AstraZeneca Chronic Kidney Disease (CKD) Financial Overview
Table GlaxoSmithKline Chronic Kidney Disease (CKD) Financial Overview
Table Roche Chronic Kidney Disease (CKD) Financial Overview
Figure Global Chronic Kidney Disease (CKD) Revenue (Millions USD) and Growth Rate (2018-2025)
Table Chronic Kidney Disease (CKD) Market Forecast by Regions (2018-2025)
Figure North America Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure United States Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure Canada Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure Mexico Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure Europe Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure Germany Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure France Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure UK Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure Russia Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure Italy Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure Rest of Europe Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure Asia-Pacific Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure China Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure Japan Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure Korea Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure India Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure Southeast Asia Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure South America Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure Brazil Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure Argentina Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure Columbia Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure Rest of South America Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure Middle East and Africa Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure Saudi Arabia Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure United Arab Emirates Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure Egypt Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure Nigeria Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure South Africa Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure Turkey Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Chronic Kidney Disease (CKD) Market Forecast (2018-2025)
Figure Global Chronic Kidney Disease (CKD) Forecast by Product Type (2018-2025)
Figure Global Chronic Kidney Disease (CKD) Market Share Forecast by Product Type (2018-2025)
Figure Global Chronic Kidney Disease (CKD) Forecast by Product Type (2018-2025)
Figure Global Chronic Kidney Disease (CKD) Forecast by Application (2018-2025)
Figure Global Chronic Kidney Disease (CKD) Market Share Forecast by Application (2018-2025)
Figure Global Chronic Kidney Disease (CKD) Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|